InfuSystem Holdings, Inc
INFUNYSEHealthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $143.4M | $134.9M | $125.8M | $109.9M | $102.4M | $97.4M |
| Operating income | $11.9M | $6.9M | $4.1M | $1.7M | $2.8M | $8.8M |
| Net income | $6.6M | $2.3M | $872,000 | $18,000 | $1.4M | $17.3M |
| Total assets | $100.6M | $103.6M | $102.9M | $99.4M | $97.6M | $97.0M |
| Total liabilities | $43.2M | $46.1M | $50.6M | $51.4M | $49.3M | $56.2M |
| Equity | $57.3M | $57.5M | $52.3M | $48.0M | $48.3M | $40.8M |
| EPS (diluted) | $0.31 | $0.11 | $0.04 | $0.00 | $0.06 | $0.80 |
| Shares out. | 21.0M | 21.3M | 20.9M | 20.5M | 20.3M | 20.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 8.3%
- Net margin
- 4.6%
- Return on equity
- 11.6%
- Return on assets
- 6.6%
- Return on capital (ROCE)
- 14.8%
- Liabilities / assets
- 43.0%
- Debt / equity
- 0.75×
- Book value / share
- $2.73
- Revenue growth (YoY)
- 6.4%
- Net income growth (YoY)
- 182.6%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 1.27grey zone
- Accruals / assets
- −17.7%clean
- Beneish M-Score
- -3.30normal
- Piotroski F-Score
- 8/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 1 warning● 5 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Altman Z″ in the grey zone
- Operating margin is positive
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 14, 2024
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2016
- NT 10-Qmissed a reporting deadline ↗May 14, 2012
- NT 10-Qmissed a reporting deadline ↗May 17, 2011
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 154,323 | 1.0 | -27.4% |
| Apr 30, 2026 | 212,417 | 1.9 | -0.1% |
| Apr 15, 2026 | 212,670 | 2.9 | -1.6% |
| Mar 31, 2026 | 216,234 | 1.9 | +26.2% |
| Mar 13, 2026 | 171,350 | 1.3 | +55.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Regulation FD disclosureMay 18, 2026
- Director / officer changeMay 14, 2026
- Director / officer change · Shareholder voteMay 12, 2026
- Results of operationsMay 7, 2026
- Regulation FD disclosureApr 30, 2026
- Changed auditorMar 19, 2026
- Regulation FD disclosureMar 16, 2026
- Regulation FD disclosureFeb 27, 2026
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.